Be Transformative For Patients
Home
Pipeline
AI Solutions
AI Solutions
ChemiRise
Orbital
Virtual screen
Intelligent-SAR
Chemi-Net
Leadership
News
News
Publications
Join Us
Contact
Pipeline
Latest progress of our drug discovery programs
Program
Target
Indication
Discovery
IND-Enabling
Phase 1
Targeted Protein Degradation
AC0699
ER Degrader
Breast Cancer
Potential best-in-class, broad mutant coverage
AC0682
ER Degrader
Breast Cancer
Potential best-in-class
AC0176
AR Degrader
Prostate Cancer
Potential best-in-class
AC0676
BTK Degrader (WT & C481S)
Hematology Oncology Indications
High selectivity
Discovery
Undisclosed
Multiple Novel E3 Ligases
Undisclosed
First-in-Class
Small Molecule (Precision Oncology)
Discovery
Undisclosed
Lung Cancer
Discovery
Undisclosed
Solid Tumors